English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA cites design flaws in rejecting REGENXBIO Hunter syndrome gene therapy
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Boehringer Ingelheim ends MASH partnership with OSE after failed phase 2 trial
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

North Carolina town emerges as key hub for next-gen obesity drug production
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Experts question centralized decision-making trend at FDA after Moderna vaccine case
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Cancer survivor credits genetic screening with early Lynch syndrome diagnosis
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Study finds weighted vests may help preserve bone during weight loss

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Bedfont Scientific celebrates gender balance for International Women’s Day

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

Refeyn highlights expanded adoption of mass photometry among CROs and CDMOs

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes